Back to search

National and Kapodistrian University of Athens

Μελέτη των διαταραχών των φυσικών αναστολέων της πήξης, του αντιγόνου von Willebrand και της πρωτεΐνης ADAMTS-13 σε πρόωρα και τελειόμηνα νεογνά με λοιμώξεις και συγγενείς καρδιοπάθειες

Abstract

dc:description

Introduction: Developmental hemostasis represents a well-known entity, encompassing the delicate discrepancies of the coagulation profile between neonates, older children and adults and the evolving maturation of hemostatic mechanism throughout childhood. Particular prothrombotic and antithrombotic factors are measured at lower levels in neonatal plasma, while other coagulation factors, mainly FVIII and VWF are elevated. Recently, great concern has arised about the role of ADAMTS-13 protein, the VWF cleaving protein in neonatal hemostasis, in health and disease. Despite the underlying differentiation, the coagulation process in neonates is balanced, thus healthy, full-term neonates do not have an increased risk either for hemorrhage or thrombosis. However, the delicate balance is easily deranged in hospitalized neonates due to prematurity, infection, perinatal stress, central catheter placement etc. Early or late onset sepsis is one of the most common complications in Neonatal Intensive Care Units (NICUs), increasing substantially morbidity and mortality. Inflammation activates the coagulation cascade and vice versa and this interplay is described by the term “immunothrombosis” or “thromboinflammation”. Immunothrombosis represents an inherent defending mechanism, however overactivation results in major, even lifethreatening complications. What is more, congenital heart defects are accompanied also by considerable alterations of the hemostatic process. The underlying pathophysiologic mechanism is multifactorial and includes liver dysfunction, secondary erythrocytosis, hypoxia etc. Furthermore, coagulation abnormalities are associated with poor prognosis in CHD, while thromboembolic complications may present many years after surgical correction. Aim: Aim of the present study was the investigation of coagulation profile, particularly clotting, anticlotting factors and ADAMTS-13 protein in preterm and term neonates with early or late sepsis, as well as congenital heart disease. Materials and methods: The infection group includes 16 premature and fullterm septic neonates and the CHD group includes 20 neonates with cyanotic or non-cyanotic heart defect. The control group includes 18 healthy neonates. Infection group: Coagulation parameters were measured initially in the acute phase of infection and secondly after recovery. The diagnosis of infection was based on clinical signs and symptoms, raised inflammatory markers and/or positive blood culture and antibiotic treatment for at least 10 days. Positive culture of blood or other normally sterile fluid was not a prerequisite for infection diagnosis due to occasional previous antibiotic administration either to mother or baby. The disease severity was assessed by nSOFA score. CHD group: The investigation of coagulation parameters was undertaken in parallel to routine laboratory tests, while coagulation tests were repeated after heart catheterization, partial or total surgical repair of underlying defect in a small subgroup of 6 neonates. The following coagulation parameters were measured: PT, APTT, Fibrinogen, FII, FVII, FVIII, FIX, FX, VWF, Rcof, AT, PC, PS, D-dimer and ADAMTS-13. Results: Infection group: Clotting times were prolonged in the acute phase of infection in comparison to controls and recovery. FII and FVII levels were lower in the acute phase of infection compared to controls. FVII concentrations were lower in the acute phase of infection compared to recovery. On the other hand, fibrinogen, FVIII and VWF were significantly higher in the acute phase in comparison to controls and recovery, while they remained persistently higher in the infection group compared to controls. In regards to anticlotting mechanism, a clear suppression was observed in septic neonates. An intriguing result was the identification of lower D-dimer levels in the infection group compared to control group. ADAMTS-13 levels were significantly lower in acute phase of infection compared to controls and recovery, while a trend towards superimposed normalization was present post infection. ROC analysis of ADAMTS-13 as a predictor of infection was AUC= 0.736, CI95% 0.564–0.908, p= 0.019. The chosen cutoff value was 545.5 ng/mL, with sensitivity 72% and specificity 75%. A significant negative correlation was demonstrated between VWF and ADAMTS-13 levels in acute phase of infection. What is more, nSOFA score was positively correlated with VWF levels and negatively correlated with ADAMTS13 levels in the acute phase of infection. CHD group: PT was significantly prolonged and accordingly FVII levels were lower in neonates with CHD compared to controls. On the other hand, FVIII, VWF and Rcof levels were substantially higher in the CHD group compared to controls, while no significant difference was demonstrated in regards to natural anticoagulants. ADAMTS-13 concentrations were lower in neonates with CHD in comparison to controls, but difference was not statistically significant. D-dimer levels were lower in neonates with CHD compared to controls, a finding doubting the traditional assumption that CHD is accompanied by lowgrade DIC. Comparison of coagulation profile between cyanotic and non-cyanotic CHD did not reveal any significant discrepancies. However, coagulation abnormalities were more pronounced in prostaglandin-dependent CHD rather than nonprostaglandin CHD. In the small group of patients that tests were repeated after cardiac catheterization or surgical repair, elevated D-dimer levels were observed post intervention. Finally, coagulation parameters were not correlated with disease severity as assessed by Bethesda classification system. However, PT was significantly prolonged and accordingly FVII levels were significantly lower in cases with poor prognosis, indicating a clear association between coagulation profile and outcome. Conclusion: The hemostatic mechanism during neonatal age represents an evolving, although balanced process. A derangement towards hemorrhage or thrombosis can rapidly develop under particular conditions. Sepsis is a well-described and common trigger of coagulation cascade, resulting in significant derangement of clotting and anticlotting mechanism. Identification of lower D-dimer levels in septic neonates compared to controls raises concerns about classical DIC diagnostic criteria and should be further investigated in future studies. The role of ADAMTS-13 in adult sepsis has been thoroughly studied. To the best of our knowledge, our study represents the first study about ADAMTS-13 implication in neonatal sepsis. Our findings indicate possible usefulness of ADAMTS-13 substitution in septic neonates, which has been proposed as an adjuvant tool in sepsis treatment, currently under investigation. CHD is associated with major morbidity and mortality and coagulation abnormalities are a poor prognostic factor. The role of ADAMTS-13 has been investigated in older children with CHD with conflicting results between studies. To the best of our knowledge, our study is the first study giving insight into the role of ADAMTS-13 in neonates with CHD. Lower levels of ADAMTS-13 in neonates with CHD indicates an additional prothrombotic risk factor in neonates with CHD.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papadogeorgou, Paraskevi
  • Παπαδογεώργου, Παρασκευή

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56680

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papadogeorgou, Paraskevi; Παπαδογεώργου, Παρασκευή. Μελέτη των διαταραχών των φυσικών αναστολέων της πήξης, του αντιγόνου von Willebrand και της πρωτεΐνης ADAMTS-13 σε πρόωρα και τελειόμηνα νεογνά με λοιμώξεις και συγγενείς καρδιοπάθειες. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56680